Navigation Links
Termination in Biological Technology

Spherix Announces Termination of Arla License Agreement

Agreement Enables Spherix to Pursue All Pharmaceutical and Health-Oriented Nutraceutical Uses of Naturlose BETHESDA, Md., June 23 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory co...

Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program

SAN FRANCISCO, Jan. 20 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), today announced that it will focus resources on the development of its natriuretic peptide franchise, including CD-NP which is in Phase II development for acute heart failure, and CU-NP which is a pre-clini...

Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners

EVALUATION OF VARIOUS FINANCIAL AND RESTRUCTURING ALTERNATIVES ONGOING VANCOUVER, Nov. 21 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that the Company had been notified ...

Protein Sciences Announces Termination of Deal to Sell to Emergent BioSolutions

- PSC terminates sale due to Emergent's breaches - PSC BLA for FluBlok remains on track with the FDA - PSC awaiting decision on BARDA contract award MERIDEN, Conn., July 29 /PRNewswire/ -- Protein Sciences Corporation ("PSC") announced today that the sale of its...

Coherent, Inc. Announces Termination of SEC Informal Inquiry

SANTA CLARA, Calif., July 10 /PRNewswire-FirstCall/ -- Coherent, Inc. (Nasdaq: COHR ), today announced that the Securities and Exchange Commission has formally notified the Company that its investigation of Coherent's historical stock option granting practices has been terminated and that it ...

Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement

NEW YORK and PARSIPPANY, N.J., May 12 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX ), a U.S.-based pharmaceutical company, and Daiichi Sankyo, Inc. today announced that they have terminated their co-promotion agreement for AZOR(TM)* (amlodipine and olmesartan medoxomil), Dai...

Lilly Announces Termination of AIR Insulin Program

INDIANAPOLIS, March 7 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced the termination of development of its AIR(R) Insulin program, which was being conducted in partnership with Alkermes, Inc. The program has been in phase III clinical development as a potential t...

Schering-Plough Shareholders Approve Merger With Merck

... to close in the 2009 fourth quarter, is subject to the satisfaction of customary closing conditions and regulatory approvals, including expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, as well as clearance by the European Comm...

Synthetech Reports First Quarter Fiscal 2010 Results

...ncial and other resources; the uncertain market for Synthetech's products; potential loss of a significant customer; customer concentration; potential termination or suspension by customers of significant projects or orders; potential period-to-period revenue or expense fluctuations; production factors and timel...

GenVec Reports Second Quarter 2009 Financial Results

...ases are partially offset in both periods by increases related to the manufacturing costs of TNFerade arising from the letter agreement and subsequent termination of our Cobra contract and increases related to manufacturing costs related to our FMD program as compared to the prior year periods. GenVec en...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...une for the treatment of IPF, an indication for which Actimmune has not been approved by the FDA, have declined significantly following the March 2007 termination of the Phase 3 INSPIRE trial of Actimmune in IPF and the risk that InterMune's revenue will continue to decline as expected; (ii) risks related to reg...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... non-recurring supply/distribution agreement termination costs. c. Research and development adjustment... $ (114) $ (189) termination and reorganization costs - ... license agreement related to our termination agreements with Lipose Corp. and Spartan ...

PDI Reports 2009 Second Quarter Financial Results

...ignment and continued cost reductions Mutual termination of product commercialization contract Appoin... force by a long-term client and the expiration or termination of other sales force arrangements in effect during...e loss contract accrual associated with the mutual termination of this contract. Total operating expenses...

PDI Appoints Gerald P. Belle as Lead Independent Director

...urcing trends or a reduction in promotional, marketing and sales expenditures in the pharmaceutical, biotechnology and life sciences industries; early termination of a significant services contract or the loss of one or more significant clients or a material reduction in service revenues from such clients; the a...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...ending on accrued projects and a gain of approximately $10.4 million on the termination of two 50% owned joint ventures with Aspen Pharmacare Holdings Limited of S...n accrued projects and a gain of approximately $10.4 million on the termination of two 50% owned joint ventures with Aspen Pharmacare Holdings Limi...

Sunesis Reports Financial Results for the Second Quarter 2009

...e decreases were primarily due to savings from the termination of substantially all discovery research activities...rst half of 2009, including $1.3 million for lease termination activities and $0.6 million for employee termination costs related to the March 2009 restructuring. For...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... and regulatory approvals, including expiration or termination of the applicable waiting period under the Hart-Sc... 2008 was $64 million of income related to the termination of a respiratory joint venture with Merck. ...---- Income from respiratory JV termination (f) $- $(64) $- $...

Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes

...ennsylvania, pursuant to which the landlord has agreed to release the Company from its remaining lease obligations of approximately $3.4 million for a termination fee of $235,000. As of the closing of the transaction, Dr. David Ginsberg, Chief Executive Officer of the Company, has joined Pierrel Resea...

Vasogen Announces Second Quarter 2009 Results

...bstantially reduced compensation, to assist the Board in bringing closure to the ongoing strategic review process. As a result of this termination the number of full-time employees has been reduced to one. - On April 24, 2009, we announced that Dr. Eldon R. Smith would succeed ...

Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers

...n time, programmable treatment protocols and more. As an added safety feature, ETC's chambers feature a full manual override system to avoid premature termination of treatment protocol as a result of power outages. ETC's Biomedical Division has been providing state of the art chambers for Hyperbaric Oxy...

Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease

...hile at Day 90 the difference was 4.73 (p=0.001). Of interest, a significant difference in cognitive test scores of 3.27 was observed two weeks after termination of AC-1202 treatment (p=0.034). This finding suggests that daily administration of AC-1202 may produce lasting effects in those patients with this co...

Pharmaxis to Voluntarily De-List from Nasdaq

... anticipated timetable for the de-listing from NASDAQ and downgrade of the ADS program is set out as follows (New York time): 3 August 2009 - termination of NASDAQ listing and change of ADS program 3 August 2009 - Registration with the SEC suspended 21 October 2009 - Deregistration with the SE...

TransTech Services Partners, Inc. Shareholders Approve Plan of Liquidation; Company To Distribute Amounts in Trust

...ering. The Company will file a certificate of dissolution with the Secretary of State of the State of Delaware and a Certification and Notice of termination of Registration on Form 15 with the Securities and Exchange Commission for the purpose of deregistering its securities under the Securities Exchange A...

Endocare and Galil Medical Announce Settlement of Litigation

...ocare, Inc. (Nasdaq: ENDO ) and privately-held Galil Medical Ltd., today announced that they have entered into a settlement agreement stipulating to termination of the previously announced merger agreement between Endocare and Galil Medical pursuant to which Endocare would have acquired Galil Medical, and the ...

iCardiac Selected by Top 10 Pharmaceutical Company

...ly clinical cardiac safety studies as well as minimize the current unacceptably high rate of false-positive QTc findings which can lead to unnecessary termination of promising new medicines in development." About iCardiac Technologies iCardiac Technologies, Inc. is a technologically differentiated card...

ULURU Discussions to Acquire York Pharma, plc Are Currently Terminated

...e terms of such facility. This revolving credit facility is secured by substantially all of the assets of York and its subsidiaries. Despite this termination of discussions with York, ULURU remains committed to pursuing strategic opportunities and partnerships in the near future. About ULURU Inc.: ...

Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St. John Wound Center

...n time, programmable treatment protocols and more. As an added safety feature, ETC's chambers feature a full manual override system to avoid premature termination of treatment protocol as a result of power outages. Gene Davis, President of ETC's BioMedical Division, commented, "Placement of the third chambe...

Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology

... JNJ ) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Ac...ules and regulations of the U.S. Securities and Exchange Commission (SEC). termination of the waiting period satisfies one of the conditions to the tender offer. ...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

...h periods ended April 30, 2008. In the first quarter of fiscal 2009 and the third quarter of fiscal 2008, license fees and royalty revenues include a termination payment and royalty revenues from Lumera Corporation totaling US$75,000 and US$100,000, respectively. All other license fees and royalties are compri...

CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement

...l analysis of the situation and all alternatives available, we believe that termination of the merger agreement is in the best interest of all parties. We are dis...eir future endeavors." Both parties will fulfill their obligations for termination contained in the merger agreement. As part of the agreement, CSL will pay ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... with CIMZIA should be closely monitored for clinical and laboratory signs of active HBV infection throughout therapy and for several months following termination of therapy. In patients who develop HBV reactivation, discontinue CIMZIA and initiate effective anti-viral therapy with appropriate supportive treatme...

Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting

...significant drug resistance" to imatinib therapy by expressing a truncated BCR-ABL1. Abstract title: "BCR-ABL1 truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors." (Abstract No: 7028) Link to ASCO abstract: http://www.abstract.asco.org/AbstView_65_33182.html ...

MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants

...nd the cashless exercise right, the terms of the Existing Warrants and the New Warrants will be identical, including the Initial Exercise Date and the termination Date. As of the date hereof there were 48 Existing Warrants outstanding representing rights to purchase a total of 354,838,221 shares of Common S...

Arena Pharmaceuticals Announces First Quarter 2009 Financial Results

...tion, Arena expects to incur cash charges, primarily in the second quarter of 2009, of approximately $3.0 million in connection with one-time employee termination costs, including severance and other benefits. This workforce reduction is expected to result in annual operating cost savings of approximately $25.0 ...

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

...une for the treatment of IPF, an indication for which Actimmune has not been approved by the FDA, have declined significantly following the March 2007 termination of the Phase 3 INSPIRE trial of Actimmune in IPF and the risk that InterMune's revenue will continue to decline as expected; (ii) risks related to reg...

Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009

...sed compensation expenses and non-recurring termination related costs were $5.7 million. These resu...-based compensation expenses, non-recurring termination related costs, certain litigation costs and ... costs deriving primarily from the completion or termination of various of our human clinical trial acti...

Shire begins the year with a strong performance

...l Co., Ltd to develop and sell LIALDA(R) (mesalamine) in Japan. termination of LIALDA co-promotion agreement - As of March 31, 2009, Shire termina...lion in Q1 2009 to reflect the cash payment made in Q1 2009 and other termination related costs. At December 31, 2008 Shire's maximum future reimbursem...

Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code

... for cause. The resigning personnel will continue to act as consultants to Vermillion. They will accrue severance and other rights as a result of the termination to the extent funds for such payments are available in the bankruptcy reorganization. About OVA1 Vermillion has multiple ovarian cancer di...

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results

...anuary 2009, Sunesis entered into an Agreement for termination of Lease and Voluntary Surrender of Premises for i...h San Francisco, CA. In consideration of the early termination of the existing lease agreement, Sunesis agreed to...crease in R&D expense was primarily due to the termination of discovery research activities in June 2008 and ...

Bavarian Nordic Publishes its Annual Results 2008

...ard of Directors and exercise is limited by and governed by the Danish Act on Options for Employees (the Stock Option Act/aktieoptionsloven) regarding termination of employment prior to exercise of warrants. A total of 25,000 warrants are awarded for subscription of up to 25,000 shares of a nominal value ...
Other Tags
(Date:9/2/2014)... Air pollution regulations over the last decade in Taiyuan, ... there, accounting for a greater than 50% reduction in ... 2001 and 2010, according to researchers at the Columbia ... School of Public Health, the Shanxi Medical University, the ... and Shanghai Fudan University School of Public Health. , ...
(Date:9/2/2014)... others are done in by it. New research at ... so-called stress gap in mice with very similar genetic ... better understand the development of psychiatric disorders such as ... unique experiences as it goes through its life. And ... expression of genes, and as a result, affect an ...
(Date:9/1/2014)... held that corals whose calcium-carbonate skeletons form ... organisms that rely entirely on ocean currents to ... But now scientists at MIT and the Weizmann ... that they are far from passive, engineering their ... greatly enhance their ability to exchange nutrients and ...
Breaking Biology News(10 mins):Clean air halves health costs in Chinese city 2Discovery hints at why stress is more devastating for some 2Discovery hints at why stress is more devastating for some 3Nature's tiny engineers 2Nature's tiny engineers 3
(Date:9/3/2014)... An inspiring story of the importance ... the season finale of “Extreme Weight Loss” Season Four. ... daughter from Highlands Ranch, Colo. who have a strained ... pounds. Their challenge is to team up to lose ... non-competitive approach to weight loss transformations, “Extreme Weight Loss” ...
(Date:9/3/2014)... Tulsa, OK (PRWEB) September 03, 2014 ... in the sales, installation, and support of Sage 100 ... named a Sage North America Million Dollar Club achiever ... 2013-2014 business year. Sage recognizes CS3 Technology and all ... to the overall success of Sage, its business partners ...
(Date:9/3/2014)... Gorda, FL (PRWEB) September 03, 2014 ... healthcare delivery, increases patient safety, decreases medical errors, ... providers. , To mark the important role ... in America, IHS and others across the U.S. ... Technology (NHIT) Week , September 16-20, 2014. With ...
(Date:9/3/2014)... September 03, 2014 Immersion Active ... received a silver medal in the 2014 Content Marketing ... Marketing Awards is the leading awards program for people ... of every medium and strategic purpose. , Immersion ... developed for its client Home Instead Senior Care®. This ...
(Date:9/3/2014)... OR (PRWEB) September 03, 2014 ... the use of appropriate evidence-based health care along ... parties benefit from the expertise of accredited independent ... the health care system. , As a core ... IROs often settle questions of medical necessity. Yet ...
Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Jeff and Juliana’s Journey begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:CS3 Technology Named a Sage Million Dollar Club Achiever for 2013-2014 2Health News:Innovative Healthcare Solutions (IHS) Celebrates National Health IT Week September, 15-19, 2014 2Health News:Immersion Active Wins Silver for Email Strategy in 2014 Content Marketing Awards 2Health News:Independent Review Expands Its Scope: Case Studies in Context 2Health News:Independent Review Expands Its Scope: Case Studies in Context 3
Other Contents